Edwards will pay $10M to settle FTC charges of skirting antitrust review

Edwards Lifesciences will pay $10 million to settle FTC allegations that it deliberately structured its acquisition of JC Medical to circumvent Hart-Scott-Rodino antitrust review requirements. The settlement addresses regulatory compliance concerns in medical device industry consolidation.